Publication Cover
Canadian Journal of Pain
Revue canadienne de la douleur
Volume 6, 2022 - Issue 1
2,890
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The relationship between patients’ income and education and their access to pharmacological chronic pain management: A scoping review

&
Pages 142-170 | Received 31 Mar 2022, Accepted 19 Jul 2022, Published online: 01 Sep 2022

References

  • Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, Cohen M, Evers S, Giamberardino MA, Goebel A, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28–37. doi:10.1097/j.pain.0000000000001390.
  • World Health Organization. International Classification of Diseases 11th Revision. https://icd.who.int/en [accessed 2021 Dec 4].
  • International Association for the Study of Pain. IASP announces revised definition of pain. 2020 [accessed 2021 Dec 4]. https://www.iasp-pain.org/publications/iasp-news/iasp-announces-revised-definition-of-pain.
  • Mills SE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273–e83. doi:10.1016/j.bja.2019.03.023.
  • Sá KN, Moreira L, Baptista AF, Yeng LT, Teixeira MJ, Galhardoni R, de Andrade DC. Prevalence of chronic pain in developing countries: systematic review and meta-analysis. PAIN Rep. 2019;4(6):e779. doi:10.1097/PR9.0000000000000779.
  • Roth RS, Punch MR, Bachman JE. Educational achievement and pain disability among women with chronic pelvic pain. J Psychosom Res. 2001;51(4):563–69. doi:10.1016/S0022-3999(01)00242-2.
  • Brady B, Veljanova I, Chipchase L. The intersections of chronic noncancer pain: culturally diverse perspectives on disease burden. Pain Med. 2019;20(3):434–45. doi:10.1093/pm/pny088.
  • Eachus J, Chan P, Pearson N, Propper C, Smith GD. An additional dimension to health inequalities: disease severity and socioeconomic position. J Epidemiol Community Health. 1999;53:603–11. doi:10.1136/jech.53.10.603.
  • Hirsh AT, Miller MM, Hollingshead NA, Anastas T, Carnell ST, Lok BC, Chu C, Zhang Y, Robinson ME, Kroenke K, et al. A randomized controlled trial testing a virtual perspective-taking intervention to reduce race and socioeconomic status disparities in pain care. Pain. 2019;160(10):2229–40. doi:10.1097/j.pain.0000000000001634.
  • Jay MA, Howard RF. Inequalities in access to a tertiary children’s chronic pain service: a cross-sectional study. Arch Dis Child. 2016;101(7):657–61. doi:10.1136/archdischild-2015-310280.
  • Kapoor S, Thorn BE. Healthcare use and prescription of opioids in rural residents with pain. Rural Remote Health. 2014;14:2879.
  • Canadian Pain Task Force. An action plan for pain in Canada. 2021. [accessed 2021 Jan 4]. https://www.canada.ca/en/health-canada/corporate/about-health-canada/public-engagement/external-advisory-bodies/canadian-pain-task-force/report-2021.html.
  • Andersson I, Ejlertsson G, Leden I, Rosenberg C. Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization. Clin J Pain. 1993;9:174–82. doi:10.1097/00002508-199309000-00004.
  • Bonathan C, Hearn L. de Williams CA. Socioeconomic status and the course and consequences of chronic pain. Pain Manag. 2013;3:159–62.
  • Green CR, Anderson KO, Baker TA, Campbell LC, Decker S, Fillingim RB, Kaloukalani DA, Lasch KE, Myers C, Tait RC, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med. 2003;4(3):277–94. doi:10.1046/j.1526-4637.2003.03034.x.
  • Poleshuck EL, Green CR. Socioeconomic disadvantage and pain. Pain. 2008;136(3):235. doi:10.1016/j.pain.2008.04.003.
  • Saastamoinen P, Leino-Arjas P, Laaksonen M, Lahelma E. Socio-economic differences in the prevalence of acute, chronic and disabling chronic pain among ageing employees. Pain. 2005;114(3):364–71. doi:10.1016/j.pain.2004.12.033.
  • Macfarlane GJ, Norrie G, Atherton K, Power C, Jones GT. The influence of socioeconomic status on the reporting of regional and widespread musculoskeletal pain: results from the 1958 British Birth Cohort Study. Ann Rheum Dis. 2009;68(10):1591–95. doi:10.1136/ard.2008.093088.
  • Morgan CL, Conway P, Currie CJ. The relationship between self-reported severe pain and measures of socio-economic disadvantage. Eur J Pain. 2011;15(10):1107–1011. doi:10.1016/j.ejpain.2011.04.010.
  • Janevic MR, McLaughlin SJ, Heapy AA, Thacker C, Piette JD. Racial and socioeconomic disparities in disabling chronic pain: findings from the health and retirement study. J Pain. 2017;18(12):1459–67. doi:10.1016/j.jpain.2017.07.005.
  • Pollack CE, Chideya S, Cubbin C, Williams B, Dekker M, Braveman P. Should health studies measure wealth? A systematic review. Am J Prev Med. 2007;33(3):250–64. doi:10.1016/j.amepre.2007.04.033.
  • Rios R, Zautra AJ. Socioeconomic disparities in pain: the role of economic hardship and daily financial worry. Health Psychol. 2011;30(1):58–66. doi:10.1037/a0022025.
  • Booher L. The impact of low socioeconomic status in adults with chronic pain. Orthopaed Nurs. 2019;38:381–89. doi:10.1097/NOR.0000000000000620.
  • Grol-Prokopczyk H. Sociodemographic disparities in chronic pain, based on 12-year longitudinal data. Pain. 2017;158(2):313–22. doi:10.1097/j.pain.0000000000000762.
  • Hardt J, Jacobsen C, Goldberg J, Nickel R, Buchwald D. Prevalence of chronic pain in a representative sample in the United States. Pain Med. 2008;9(7):803–12. doi:10.1111/j.1526-4637.2008.00425.x.
  • Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an internet-based survey. J Pain. 2010;11(11):1230–39. doi:10.1016/j.jpain.2010.07.002.
  • Portenoy RK, Ugarte C, Fuller I, Haas G. Population-based survey of pain in the United States: differences among white, African American, and Hispanic subjects. J Pain. 2004;5(6):317–28. doi:10.1016/j.jpain.2004.05.005.
  • Riskowski JL. Associations of socioeconomic position and pain prevalence in the United States: findings from the National Health and Nutrition Examination Survey. Pain Med. 2014;15(9):1508–21. doi:10.1111/pme.12528.
  • Jöud A, Petersson IF, Jordan KP, Lofvendahl S, Grahn B, Englund M. Socioeconomic status and the risk for being diagnosed with spondyloarthritis and chronic pain: a nested case–control study. Rheumatol Int. 2014;34(9):1291–98. doi:10.1007/s00296-014-3039-6.
  • Kapteyn A, Smith JP, van Soest A. Dynamics of work disability and pain. J Health Econ. 2008;27(2):496–509. doi:10.1016/j.jhealeco.2007.05.002.
  • Yoon YS, Oh SW, Park HS. Socioeconomic status in relation to obesity and abdominal obesity in Korean adults: a focus on sex differences. Obesity. 2006;14(5):909–19. doi:10.1038/oby.2006.105.
  • Roth RS, Geisser ME. Educational achievement and chronic pain disability: mediating role of pain-related cognitions. Clin J Pain. 2002;18(5):286–96. doi:10.1097/00002508-200209000-00003.
  • Lacey RJ, Belcher J, Croft PR. Does life course socio-economic position influence chronic disabling pain in older adults? A general population study. Eur J Pub Health. 2013;23(4):534–40. doi:10.1093/eurpub/cks056.
  • Larson AG, Marcer D. The who and why of pain: analysis by social class. BMJ. 1984;288(6421):883–86. doi:10.1136/bmj.288.6421.883.
  • Boulton M, Tuckett D, Olson C, Williams A. Social class and the general practice consultation. Sociol Health Illness. 1986;8(4):325–50. doi:10.1111/1467-9566.ep11340453.
  • Waitzkin HB. Doctor-patient communication: clinical implications of social scientific research. JAMA. 1984;252(17):2441–46. doi:10.1001/jama.1984.03350170043017.
  • Williams MV, Parker RM, Baker DW. Inadequate health literacy among patients at two public hospitals. JAMA. 1995;274:1677–82. doi:10.1001/jama.1995.03530210031026.
  • Pendleton DA, Bochner S. The communication of medical information in general practice consultations as a function of patients’ social class. Soc Sci Med. 1980;14A:669–73.
  • Stewart M. Patient characteristics which are related to the doctor-patient interaction. Fam Pract. 1984;1(1):30–35. doi:10.1093/fampra/1.1.30.
  • Street RL; Street RL Jr. Information-giving in medical consultations: the influence of patients‘ communicative styles and personal characteristics. Soc Sci Med. 1991;32(5):541–48. doi:10.1016/0277-9536(91)90288-N.
  • Bergenudd H, Nilson B. Back pain in middle age: occupational workload and psychological factors: an epidemiological survey. Spine. 1988;13:58–60. doi:10.1097/00007632-198801000-00014.
  • Bigos SJ, Battie MC, Spengler DM, Fisher LD, Fordyce WE, Hansson T, Nachemson AL, Zeh J. A Longitudinal, Prospective Study of Industrial Back Injury Reporting. Clin Orthop. 1992;279:21–34. doi:10.1097/00003086-199206000-00004.
  • Cats-Baril WL, Frymoyer JW. Demographic factors associated with the prevalence of disability in the general population: analysis of the NHANES I database. Spine. 1991;16(6):671–74. doi:10.1097/00007632-199106000-00019.
  • Deyo RA, Diehl AK. Psychosocial predictors of disability in patients with low back pain. J Rheumatol. 1988;15:1557–64.
  • Matthews KA. Are sociodemographic variables markers for psychological determinants of health? Health Psychol. 1989;8(6):641–48. doi:10.1037/0278-6133.8.6.641.
  • Mnm VP, Koes BW, Deville W, Smid T, Bouter LM. Risk factors for back pain incidence in industry: a prospective study. Pain. 1998;77:81–86. doi:10.1016/S0304-3959(98)00085-2.
  • Geisser ME, Robinson ME, Henson CD. Coping Strategies Questionnaire and chronic pain adjustment: a conceptual and empirical analysis. Clin J Pain. 1994;10:98–106. doi:10.1097/00002508-199406000-00003.
  • Pincus T. Formal educational level--a marker for the importance of behavioral variables in the pathogenesis, morbidity, and mortality of most diseases? J Rheumatol. 1988;15:1457–60.
  • Sullivan MJL, Stanish W, Waite H, Sullivan M, Tripp DA. Catastrophizing, pain, and disability in patients with soft-tissue injuries. Pain. 1998;77(3):253–60. doi:10.1016/S0304-3959(98)00097-9.
  • Turner JA, Clancy S. Strategies for coping with chronic low back pain: relationship to pain and disability. Pain. 1986;24(3):355–64. doi:10.1016/0304-3959(86)90121-1.
  • Odubanjo E, Bennett K, Feely J. Influence of socioeconomic status on the quality of prescribing in the elderly–a population based study. Br J Clin Pharm. 2004;58:496–502. doi:10.1111/j.1365-2125.2004.02179.x.
  • Asamoah-Boaheng M, Badejo OA, Bell LV, Buckley N, Busse JW, Campbell TS, Corace K, Cooper L, Flusk D, Garcia DA, et al. Interventions to influence opioid prescribing practices for chronic noncancer pain: a systematic review and meta-analysis. Am J Prev Med. 2021;60(1):e15–e26. doi:10.1016/j.amepre.2020.07.012.
  • Kay C, Wozniak E, Koller S, Ye A, Bernstein J. Adherence to chronic opioid therapy prescribing guidelines in a primary care clinic. J Opioid Manag. 2016;12:333–45. doi:10.5055/jom.2016.0350.
  • McCalmont JC, Jones KD, Bennett RM, Friend R. Does familiarity with CDC guidelines, continuing education, and provider characteristics influence adherence to chronic pain management practices and opioid prescribing? J Opioid Manag. 2018;14:103–16. doi:10.5055/jom.2018.0437.
  • Victor TW, Alvarez NA, Gould E. Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence practice. J Pain. 2009;10:1051–57. doi:10.1016/j.jpain.2009.03.019.
  • Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. doi:10.1186/s12874-018-0611-x.
  • Campbell LC, Robinson K, Meghani SH, Vallerand A, Schatman M, Sonty N. Challenges and opportunities in pain management disparities research: implications for clinical practice, advocacy, and policy. J Pain. 2012;13(7):611–19. doi:10.1016/j.jpain.2012.02.004.
  • Webster F, Connoy L, Sud A, Pinto AD, Katz J. Grappling with chronic pain and poverty during the COVID-19 pandemic. Can J Pain. 2020;4:125–28. doi:10.1080/24740527.2020.1766855.
  • Anastas TM, Miller MM, Hollingshead NA, Stewart JC, Rand KL, Hirsh AT. The unique and interactive effects of patient race, patient socioeconomic status, and provider attitudes on chronic pain care decisions. Ann Behav Med. 2020;54(10):771–82. doi:10.1093/abm/kaaa016.
  • Bankole A. The relationship between socioeconomic factors and DMARDs use in rheumatoid arthritis. Arthritis Rheumatol. 2016;68:150–51.
  • Baser O, Wang L, Li L, Xie L. Characteristics associated with initiation of intravenous vs subcutaneous injection tumor necrosis factor inhibitors for rheumatoid arthritis patients. Pharmacoepidemiol Drug Saf. 2013;22:498.
  • Bigal ME, Buse DC, Chen Y-T, Golden W, Serrano D, Chu MK, Lipton RB. Rates and predictors of starting a triptan: results from the American migraine prevalence and prevention study. Headache. 2010;50(9):1440–48. doi:10.1111/j.1526-4610.2010.01703.x.
  • Chuang E, Gil EN, Gao Q, Kligler B, McKee MD. Relationship between opioid analgesic prescription and unemployment in patients seeking acupuncture for chronic pain in urban primary care. Pain Med. 2019;20(8):1528–33. doi:10.1093/pm/pny169.
  • Codreanu C, Popescu CC, Mogoşan, C. Area of residence and socioeconomic factors reduce access to biologics for rheumatoid arthritis patients in Romania. BioMed Res Int. 2018:7458361.
  • Fanciullo GJ, Ball PA, Girault G, Rose RJ, Hanscom B, Weinstein JN. An observational study on the prevalence and pattern of opioid use in 25,479 patients with spine and radicular pain. Spine. 2002;27(2):201–05. doi:10.1097/00007632-200201150-00016.
  • Frisell T, Baecklund E, Bengtsson K, Di Giuseppe D, Forsblad-d’Elia H, Askling J. Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics. Ann Rheum Dis. 2018;77(5):650–57. doi:10.1136/annrheumdis-2017-212395.
  • Grol-Prokopczyk H. Use and opinions of prescription opioids among older American adults: sociodemographic predictors. J Gerontol B Psychol Soc Sci. 2019;74:1009–19. doi:10.1093/geronb/gby093.
  • Kuo Y-F, Raji MA, Chen N-W, Hasan H, Goodwin JS. Trends in opioid prescriptions among Part D Medicare recipients from 2007 to 2012. Am J Med. 2016;129(2):221.e21–221.e30. doi:10.1016/j.amjmed.2015.10.002.
  • Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Headache. 2013;53:81–92. doi:10.1111/j.1526-4610.2012.02265.x.
  • McKeown T, Jacob B, Li X, Couto S, Bensen W, Ahluwalia V, Karasik A, Bombardier C. Comparison of medication use in rheumatoid arthritis patients between university and private settings – results from ontario best practice research initiative. J Rheumatol. 2015;42:1324.
  • Nampiaparampil DE, Nampiaparampil JX, Harden RN. Pain and prejudice. Pain Med. 2009;10(4):716–21. doi:10.1111/j.1526-4637.2009.00612.x.
  • Nielsen S, Campbell G, Peacock A, Smith K, Bruno R, Hall W, Cohen M, Degenhardt L. Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study. Aust Health Rev. 2016;40(5):490–99. doi:10.1071/AH15047.
  • Nikiphorou E, van der Heijde D, Norton S, Rbm L, Molto A, Dougados M, Van den Bosch FE, Ramiro S. Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study. Ann Rheum Dis. 2018;77:405–11. doi:10.1136/annrheumdis-2017-212457.
  • Pensa MA, Galusha DH, Cantley LF. Patterns of opioid prescribing and predictors of chronic opioid use in an industrial cohort, 2003 to 2013. J Occup Environ Med. 2018;60(5):457–61. doi:10.1097/JOM.0000000000001231.
  • Putrik P, Ramiro S, Lie E, Keszei AP, Kvien TK, van der Heijde D, Landewé R, Uhlig T, Boonen A. Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD. Rheumatology. 2016;55(7):1217–24. doi:10.1093/rheumatology/kew048.
  • Shmagel A, Ngo L, Ensrud K, Foley R. Prescription medication use among community-based U.S. adults with chronic low back pain: a cross-sectional population based study. J Pain. 2018;19(10):1104–12. doi:10.1016/j.jpain.2018.04.004.
  • Stokes A, Berry KM, Hempstead K, Lundberg DJ, Neogi T. Trends in prescription analgesic use among adults with musculoskeletal conditions in the United States, 1999-2016. JAMA Network Open. 2019a;2(12):e1917228. doi:10.1001/jamanetworkopen.2019.17228.
  • Stokes A, Berry KM, Hempstead K, Neogi T. Trends in prescription pain management among US adults with arthritis or back pain, 1999-2014. Osteoarthritis and Cartilage. 2019b;27:S279–280. doi:10.1016/j.joca.2019.02.662.
  • Tamayo-Sarver JH, Dawson NV, Hinze SW, Cydulka RK, Wigton RS, Albert JM, Ibrahim SA, Baker DW. The effect of race/ethnicity and desirable social characteristics on physicians’ decisions to prescribe opioid analgesics. Acad Emerg Med. 2003;10:1239–48. doi:10.1197/S1069-6563(03)00494-9.
  • Tatangelo M, Tomlinson G, Paterson JM, Ahluwalia V, Kopp A, Gomes T, Bansback N, Bombardier C. Association of patient, prescriber, and region with the initiation of first prescription of biologic disease-modifying antirheumatic drug among older patients with rheumatoid arthritis and identical health insurance coverage. JAMA Network Open. 2019;2(12):e1917053. doi:10.1001/jamanetworkopen.2019.17053.
  • Wang P-J, Chou Y-J, Lee C-H C-H, Pu C. Diffusion of new medication across different income groups under a universal health insurance program: an example involving newly enlisted nonsteroidal anti-inflammatory drugs for elderly osteoarthritis patients. Int J Public Health. 2010;55(5):497–506. doi:10.1007/s00038-010-0132-9.
  • Yelin E, Tonner C, Kim SC, Katz JN, Ayanian JZ, Brookhart MA, Solomon DH. Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal study. Arthritis Care Res. 2014;66(7):980–89. doi:10.1002/acr.22244.
  • Celentano DD, Stewart WF, Lipton RB, Reed ML. Medication use and disability among migraineurs: a national probability sample survey. Headache. 1992;32(5):223–28. doi:10.1111/j.1526-4610.1992.hed3205223.x.
  • Chu MK, Buse DC, Bigal ME, Serrano D, Lipton RB. Factors associated with triptan use in episodic migraine: results from the American migraine prevalence and prevention study. Headache. 2012;52(2):213–23. doi:10.1111/j.1526-4610.2011.02032.x.
  • Frenk SM, Porter KS, Paulozzi LJ. Prescription opioid analgesic use among adults: united States, 1999-2012. NCHS Data Brief. 2015;189:1–8.
  • Lacaille D, Anis AH, Guh DP, Esdaile JM. Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum. 2005;53(2):241–48. doi:10.1002/art.21077.
  • Schmajuk G, Trivedi A, Solomon D, Yelin E, Trupin L, Chakravarty E, Yazdany J. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. JAMA. 2011;305(5):480–86. doi:10.1001/jama.2011.67.
  • Wu J, Noxon V, Lu ZK. Patterns of use and health expenses associated with triptans among adults with migraines. Clin J Pain. 2015;31(8):673–79. doi:10.1097/AJP.0000000000000152.
  • Yazdany J, Tonner C, Schmajuk G, Lin GA, Trivedi AN. Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis. Arthritis Care Res. 2014;66(10):1447–55. doi:10.1002/acr.22312.
  • Abbott S, Hobby L. Welfare benefits advice in primary care: evidence of improvements in health. Public Health. 2000;114(5):324–27. doi:10.1038/sj.ph.1900680.
  • Ackerman SJ, Steinberg EP, Bryan RN, BenDebba M, Long DM. Patient characteristics associated with diagnostic imaging evaluation of persistent low back problems. Spine. 1997;22(14):1634–40. doi:10.1097/00007632-199707150-00021.
  • Adler NE, Stead WW. Patients in context—EHR capture of social and behavioral determinants of health. N Engl J Med. 2015;70:388–90.
  • Alford DP. Opioid Prescribing for Chronic Pain — achieving the Right Balance through Education. N Engl J Med. 2016;374(4):301–03. doi:10.1056/NEJMp1512932.
  • Bansback N, Young A, Brennan A, Dixey J. A prognostic model for functional outcome in early rheumatoid arthritis. J Rheumatol. 2006;33:1503–10.
  • Bourne PA. Socio-demographic determinants of health care-seeking behaviour, self-reported illness and self-evaluated health status in Jamaica. Int J Collab Res Int Med Public Health. 2009;1:101–30.
  • Cerdá M, Gaidus A, Keyes KM, Ponicki W, Martins S, Galea S, Gruenewald P. Prescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areas. Addiction. 2017;112(1):103–12. doi:10.1111/add.13543.
  • Chang YP. Factors associated with prescription opioid misuse in adults aged 50 or older. Nurs Outlook. 2018;66:112–20. doi:10.1016/j.outlook.2017.10.007.
  • Cooper F, Marx BL, Lee TL, Espesete D. Super-users at an acupuncture and oriental medicine teaching clinic: demographics and unique clinical characteristics. J Altern Complement Med. 2017;23(3):222–26. doi:10.1089/acm.2016.0419.
  • Dora-Laskey A, Goldstick J, Bohnert A, Lisa B, Cunningham R, Carter PM. Predictors of misuse among adult emergency department patients using prescription opioids. Acad Emerg Med. 2018;25:S185.
  • Feingold D, Goor-Aryeh I, Bril S, Delayahu Y, Lev-Ran S. Problematic use of prescription opioids and medicinal cannabis among patients suffering from chronic pain. Pain Med. 2017;18(2):294–306. doi:10.1093/pm/pnw134.
  • Haetzman M, Elliott AM, Smith BH, Hannaford P, Chambers WA. Chronic pain and the use of conventional and alternative therapy. Fam Pract. 2003;20(2):147–54. doi:10.1093/fampra/20.2.147.
  • Havens JR, Stoops WW, Leukefeld CG, Garrity TF, Carlson RG, Falck R, Wang J, Booth BM. Prescription opiate misuse among rural stimulant users in a multistate community-based study. The American Journal of Drug and Alcohol Abuse. 2009;35(1):18–23. doi:10.1080/00952990802326298.
  • Hurstak EE, Kushel M, Chang J, Ceasar R, Zamora K, Miaskowski C, Knight K. The risks of opioid treatment: perspectives of primary care practitioners and patients from safety-net clinics. Substance Abuse. 2017;38(2):213–21. doi:10.1080/08897077.2017.1296524.
  • Khodneva Y, Muntner P, Kertesz S, Howard G, Safford M. Prescription opioid use is associated with increased mortality in the reasons for geographic and racial differences in stroke study. Drug and Alcohol Dependence. 2015;146:e157. doi:10.1016/j.drugalcdep.2014.09.345.
  • Kikano GE, Schiaffino MA, Zyzanski SJ. Medical decision making and perceived socioeconomic class. Arch Fam Med. 1996;5:267. doi:10.1001/archfami.5.5.267.
  • Licciardone JC, Pandya V. Use of complementary health approaches for chronic low-back pain: a pain research registry-based study. J Altern Complement Med. 2020;26(5):369–75. doi:10.1089/acm.2019.0448.
  • Owen-Smith A, Stewart C, Sesay MM, Strasser SM, Yarborough BJ, Ahmedani B, Miller-Matero LR, Waring SC, Haller IV, Waitzfelder BE, Sterling SA. Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness. BMC Psychiatry. 2020;20:40. doi:10.1186/s12888-020-2456-1.
  • Riley III JL, King C. Self-report of alcohol use for pain in a multi-ethnic community sample. The Journal of Pain. 2009;10(9):944–52. doi:10.1016/j.jpain.2009.03.005.
  • Walker MJ, Webster LR. Risk factors for drug diversion in a pain clinic patient population. J Opioid Manag. 2012;8:351–62. doi:10.5055/jom.2012.0135.
  • Wallace LS, Keenum AJ, Roskos SE, McDaniel KS. Development and validation of a low-literacy opioid contract. J Pain. 2007;8(10):759–66. doi:10.1016/j.jpain.2007.05.004.
  • Ward L, Patel NM, Hanlon A, Eldakar-Hein S, Sherlinski K, Ward SH. Prescription medication borrowing among adult patients at an urban medical center. J Urban Health. 2011;88(6):997–1014. doi:10.1007/s11524-011-9589-y.
  • Wilkie R, Jordan JL, Muller S, Nicholls E, Healey EL. Van Der Windt DA. Measures of social function and participation in musculoskeletal populations: impact on participation and autonomy (IPA), Keele Assessment of Participation (KAP), Participation Measure for Post-Acute Care (PM-PAC), Participation Objective, Participation S. Arthritis Care Res. 2011;63:S325–S336.
  • Adams J, Peng W, Cramer H, Sundberg T, Moore C, Amorin-Woods L, Sibbritt D, Lauche R. The prevalence, patterns, and predictors of chiropractic use among US adults. Spine. 2017;42(23):1810–16. doi:10.1097/BRS.0000000000002218.
  • Armstrong AR, Thiébaut SP, Brown LJ, Nepal B. Australian adults use complementary and alternative medicine in the treatment of chronic illness: a national study. Aust N Z J Public Health. 2011;35:384–90. doi:10.1111/j.1753-6405.2011.00745.x.
  • Beer K, Henderson JCR, Papaleontiou M, Olkhovskaya Y, Wigglesworth J, Reid MC. Physical Therapists‘ Use of Cognitive-Behavioral Therapy for Older Adults With Chronic Pain: a Nationwide Survey. Phys Ther. 2009;89(5):456–69. doi:10.2522/ptj.20080163.
  • Bruns EB, Befus D, Wismer B, Knight K, Adler SR, Leonoudakis-Watts K, Thompson-Lastad A, Chao MT. Vulnerable Patients‘ Psychosocial Experiences in a Group-Based, Integrative Pain Management Program. J Altern Complement Med. 2019;25(7):719–26. doi:10.1089/acm.2019.0074.
  • Bujold E, Huff J, Staton EW, Pace WD. Improving use of narcotics for nonmalignant chronic pain: a lesson from Community Care of North Carolina. J Opioid Manag. 2012;8:363–67. doi:10.5055/jom.2012.0136.
  • Cheng T, D’Amico S, Luo M, Lestoquoy AS, Yinusa-Nyahkoon L, Laird LD, Gardiner PM. Health disparities in access to nonpharmacologic therapies in an urban community. J Altern Complement Med. 2019;25(1):48–60. doi:10.1089/acm.2018.0217.
  • Cherniack EP, Senzel RS, Pan CX. Correlates of use of alternative medicine by the elderly in an urban population. J Altern Complement Med. 2001;7(3):277–80. doi:10.1089/107555301300328160.
  • Forestier R, André-Vert J, Guillez P, Coudeyre E, M-m L-C, Combe B, Mayoux-Benhamou MA. Non-pharmacological non-surgical treatment of rheumatoid arthritis: medicosocial and organizational aspects. Kinestherapie. 2012;12:30–40.
  • Hurstak EE, Wismer B, Leonoudakis K, Pace J, Chao MT. Integrative pain management clinic serving high risk primary care patients with chronic pain. J Gen Intern Med. 2017;32:S773.
  • Jinks C, Vohora K, Young J, Handy J, Porcheret M, Jordan KP. Inequalities in primary care management of knee pain and disability in older adults: an observational cohort study. Rheumatology. 2011;50(10):1869–78. doi:10.1093/rheumatology/ker179.
  • Joines JD, Hertz-Picciotto I, Carey TS, Gesler W, Suchindran C. A spatial analysis of county-level variation in hospitalization rates for low back problems in North Carolina. Soc Sci Med. 2003;56(12):2541–53. doi:10.1016/S0277-9536(02)00295-2.
  • Jong M, Kraishi M. A comparative study on the utility of telehealth in the provision of rheumatology services to rural and northern communities. Int J Circumpolar Health. 2004;63(4):415–21. doi:10.3402/ijch.v63i4.17758.
  • Laliberté M, Mazer B, Orozco T, Chilingaryan G, Williams-Jones B, Hunt M, Feldman DE. Implicit biases influencing service provision in physical therapy for low back pain. Arthritis Rheumatol. 2016;68:1599.
  • Lillefjell M, Haugan T, Martinussen P, Halvorsen T. Treatment Outcomes Among Individuals in a Musculoskeletal Pain Rehabilitation Program Related to the Prevalence and Trends in the Dispensing of Prescribed Medications. J Musculoskelet Pain. 2013;21(4):311–19. doi:10.3109/10582452.2013.848968.
  • Loeser JD. Comprehensive pain programs versus other treatments for chronic pain. J Pain. 2006;7(11):800–01. doi:10.1016/j.jpain.2006.09.008.
  • Ludwick A, Corey K, Meghani S. Racial and socioeconomic factors associated with the use of complementary and alternative modalities for pain in cancer outpatients: an integrative review. Pain Manag Nurs. 2020;21:142–50. doi:10.1016/j.pmn.2019.08.005.
  • Newman AK, Kapoor S, Thorn BE. Health care utilization for chronic pain in low-income settings. Pain Med. 2018;19(12):2387–97. doi:10.1093/pm/pny119.
  • Nyiendo J, Haas M, Goldberg B, Sexton G. Patient characteristics and physicians’ practice activities for patients with chronic low back pain: a practice-based study of primary care and chiropractic physicians. J Manipul Physiol Therap. 2001;24:92–100. doi:10.1067/mmt.2001.112565.
  • Proctor TJ, Mayer TG, Theodore B, Gatchel RJ. Failure to complete a functional restoration program for chronic musculoskeletal disorders: a prospective 1-year outcome study. Arch Phys Med Rehabil. 2005;86(8):1509–15. doi:10.1016/j.apmr.2005.02.010.
  • Roy P, Jackson AH, Baxter J, Brett B, Winter M, Hardesty I, Alford DP. Utilizing a faculty development program to promote safer opioid prescribing for chronic pain in internal medicine resident practices. Pain Med. 2019;20(4):707–16. doi:10.1093/pm/pny292.
  • Sundberg T, Cramer H, Sibbritt D, Adams J, Lauche R. Prevalence, patterns, and predictors of massage practitioner utilization: results of a US nationally representative survey. Musculoskelet Sci Pract. 2017;32:31–37. doi:10.1016/j.msksp.2017.07.003.
  • Tuakli-Wosornu YA, Selzer F, Losina E, Katz JN. Predictors of exercise adherence in patients with meniscal tear and osteoarthritis. Arch Phys Med Rehabil. 2016;97(11):1945–52. doi:10.1016/j.apmr.2016.05.011.
  • Turner BJ, Rodriguez N, Liang Y, Valerio M, Winkler P, Potter J, Avant K, Hill J. Use of exercise versus pain medications for chronic pain: analysis of a population-based sample of Hispanics from five states. J Gen Intern Med. 2016;31:S453–S454.
  • Turner B, Rodriguez N, Valerio M, Liang Y, Winkler P, Jackson L. Challenges for U S National Pain Strategy in low income population. J Pain. 2017;18:S62.
  • Turner BJ, Rodriguez N, Valerio MA, Liang Y, Winkler P, Jackson L. Less exercise and more drugs: how a low-income population manages chronic pain. Arch Phys Med Rehabil. 2017;98(11):2111–17. doi:10.1016/j.apmr.2017.02.016.
  • Ünsal A, Gözüm S. Use of complementary and alternative medicine by patients with arthritis. J Clin Nurs. 2010;19(7–8):1129–38. doi:10.1111/j.1365-2702.2009.03111.x.
  • Van Der Vaart R, Van Driel D, Pronk K, Paulussen S. te Boekhorst S, Rosmalen JGM, Evers AWM. The Casing should be initial caps: role of age, education, and digital health literacy in the usability of internet-based cognitive behavioral therapy for chronic pain mixed Methods Study J Med Internet Res. 2019;21:e12883.
  • Vina ER, Ran D, Ashbeck EL, Kaur M, Kwoh CK. Relationship between knee pain and patient preferences for joint replacement: health care access matters. Arthritis Care Res. 2017;69(1):95–103. doi:10.1002/acr.23084.
  • Vina ER, Ran D, Hannon MJ, Kwoh CK. Understanding ethnic differences in the utilisation of exercise for osteoarthritis. Ann Rheum Dis. 2018;77:519.
  • Ahluwalia V, Movahedi M, Rampakakis E, Cesta A, Li X, Couto S, Sampalis J, Bombardier C. Predictors of patient reported decision to discontinue anti-rheumatic medication in rheumatoid arthritis patients: data from a rheumatoid arthritis cohort. J Rheumatol. 2017;44:939–40.
  • Ahluwalia V, Movahedi M, Rampakakis E, Cesta A, Li X, Sampalis JS, Bombardier C. Predictors of non-adherence with anti-rheumatic medication in rheumatoid arthritis patients: data from a rheumatoid arthritis cohort. Arthritis Rheumatol. 2016;68:4127–30.
  • Alhefny -AE-AM, Mobasher SA, Abd El-Rahman MA, Shedid NH, Sakr HM, Hassan RM. Evaluation of adherence to drug treatment in patients with rheumatoid arthritis. Ann Rheum Dis. 2017;76:1145.
  • Ali MW, Musami UB, Sa’ad FK, Omoaghe C, Danimoh MA, Ayoola YA, Kanu AO. Profile of migraine patients in a developing country: a multicentre study. SN Comprehensive Clinical Medicine. 2020;2(8):1153–57. doi:10.1007/s42399-020-00394-x.
  • Alexandria V. Study indicates low arthritis medication adherence rate in diverse population. PT in Motion. 2013;5:11.
  • Alkabbani W, Marrie RA, Bugden S, Alessi‐Severini S, Bolton JM, Daeninck P, Leong C. Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study. Addiction. 2019;114(10):1791–99. doi:10.1111/add.14719.
  • Allen C, Murphy A, Kiselbach S, VandenBerg S, Wiebe E. Exploring the experience of chronic pain among female Survival Sex Workers: a qualitative study. BMC Fam Pract. 2015;16(1):182. doi:10.1186/s12875-015-0395-6.
  • Allen KD, Bosworth HB, Chatterjee R, Coffman CJ, Corsino L, Jeffreys AS, Oddone EZ, Stanwyck C, Yancy WS, Dolor RJ. Clinic variation in recruitment metrics, patient characteristics and treatment use in a randomized clinical trial of osteoarthritis management. BMC Musculoskelet Dis. 2014;15(1):413. doi:10.1186/1471-2474-15-413.
  • Alvarez Nemegyei J, López Salas SJ, Aguilar Erosa JA, Marín Ordóñez J, Angulo Ramírez AV. Effect of clinical and sociodemographic factors on drug treatment adherence in rheumatoid arthritis. J Rheumatol. 2011;38:1199.
  • Antoniou T, Ala-Leppilampi K, Shearer D, Parsons JA, Tadrous M, Gomes T. “Like being put on an ice floe and shoved away”: a qualitative study of the impacts of opioid-related policy changes on people who take opioids. Int J Drug Policy. 2019;66:15–22. doi:10.1016/j.drugpo.2019.01.015.
  • Argoff C, Stanos S, Irving G, Puenpatom R, Zhao S, Gould E. Demographic characteristics of patients prescribed chronic opioid therapy for chronic noncancer pain: data from the opioid utilization study (OPUS). J Pain. 2010;11(4):S46. doi:10.1016/j.jpain.2010.01.192.
  • Bansal K, Rajput SK, Sharma V, Mathur VS. Comparative analysis of socio-economic status in RHD patients: a tertiary care interpretation and exploring reasons to improve adherence. Int J Pharm Sci Res. 2019;10:790–94.
  • Barbosa HD, Nogueira AA, Silva JC, Poli Neto OB, Reis FJ. The influence of education and depression on autonomy of women with chronic pelvic pain: a cross-sectional study. Revista Brasileira de Ginecologia e Obstetrícia. 2016;38:47–52. doi:10.1055/s-0035-1570107.
  • Barbuto JP, White JGL, Porucznik CA, Holmes EB. Chronic pain: second, do no harm. Am J Phys Med Rehabil. 2008;87(1):78–83. doi:10.1097/PHM.0b013e31815e87b1.
  • Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, Dieppe P. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess (Rockv). 2005;9(38):iii–152. doi:10.3310/hta9380.
  • Bartuschka A, Dorner TE, Zeinlinger R, Fenzl KH, Mustak M, Erlacher L. Adherence with medication in patients with rheumatoid arthritis and association of socioeconomic variables with adherence. J fur Mineralstoffwechsel. 2014;21:129–30.
  • Bazargan M, Cobb S, Wisseh C, Assari S. Psychotropic and opioid-based medication use among economically disadvantaged African-American older adults. Pharmacy. 2020;8(2):74. doi:10.3390/pharmacy8020074.
  • Beatty PW, Hagglund KJ, Neri MT, Dhont KR, Clark MJ, Hilton SA. Access to health care services among people with chronic or disabling conditions: patterns and predictors. Arch Phys Med Rehabil. 2003;84:1417–25. doi:10.1016/S0003-9993(03)00268-5.
  • Befus DR, Irby MB, Coeytaux RR, Penzien DB. A critical exploration of migraine as a health disparity: the imperative of an equity-oriented, intersectional approach. Curr Pain Headache Rep. 2018;22(12):79. doi:10.1007/s11916-018-0731-3.
  • Bekanich SJ, Wanner N, Junkins S, Mahoney K, Kahn KA, Berry CA, Stowell SA, Gardner AJ. A multifaceted initiative to improve clinical awareness of pain management disparities. Am J Med Quality. 2014;29:388–96. doi:10.1177/1062860613503897.
  • Benson C, Kim M, Chow W, Wang L. Demographic and characteristics of patients from the Oxycodone Users Registry (OUR): a prospective, multicenter registry of patients with non-malignant pain. J Pain. 2010;11:S47.
  • Brandão T, Campos L, De Ruddere L, Goubert L, Bernardes SF. Classism in pain care: the role of patient socioeconomic status on nurses’ pain assessment and management practices. Pain Med. 2019;20(11):2094–105. doi:10.1093/pm/pnz148.
  • Breuer B, Pappagallo M, Tai JY, Portenoy PK. U S Board-certified pain physician practices: uniformity and census data of their locations. J Pain. 2007;8:244–50.
  • Broekmans S, Dobbels F, Milisen K, Morlion B, Vanderschueren S. Determinants of medication underuse and medication overuse in patients with chronic non-malignant pain: a multicenter study. Int J Nurs Stud. 2010;47(11):1408–17. doi:10.1016/j.ijnurstu.2010.03.014.
  • Brown EM, Garneau KL, Tsao H, Solomon DH. DMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviews. Arthritis Res Ther. 2014;16(1):1–7. doi:10.1186/ar4459.
  • Buse DC, Nicholson RA, Araujo AB, Reed ML, Shapiro RE, Ashina S, Jaffe DH, Cambron-Mellott M, Li VW, Zagar A, et al. Migraine Care Across the Healthcare Landscape in the United States among those with≥= 4 Migraine Headache Days Per Month: results of the OVERCOME Study. Headache. 2019;59:16–17.
  • Cano A, Mayo A, Ventimiglia M. Coping, pain severity, interference, and disability: the potential mediating and moderating roles of race and education. J Pain. 2006;7(7):459–68. doi:10.1016/j.jpain.2006.01.445.
  • Cantor M, Leon I, Pulgarin CP. Facts and facets: using a citywide dataset to analyze the impact of community-level social determinants on clinical outcomes. J Gen Intern Med. 2018;33:201.
  • Carter C, Goldfarb NI, Hartmann CW, Roumm AR, Vallow SM, Durkin M. Chronic pain management in managed care organizations: a national survey of medical directors. P & T. 2003;28:179–84.
  • Chaudhary N, Longworth S, Sell PJ. Management of mechanical low back pain: a survey of beliefs and attitudes in GPs from Leicester and Nottingham. European J Gen Pract. 2004;10:71–72. doi:10.3109/13814780409094238.
  • Choi J, Michael A, Michael D, Rothrock JF. A regional comparison of headache clinic populations: demography, diagnoses and frequencies/types of symptomatic medicaton overuse. Headache. 2016;56:45–46.
  • Choi NG, Snow AL, Kunik ME. Pain severity, interference, and prescription analgesic use among depressed, low-income homebound older adults. Aging Ment Health. 2016;20:804–13. doi:10.1080/13607863.2015.1037244.
  • Cisternas MG, Yelin E, Katz JN, Solomon DH, Wright EA, Losina E. Ambulatory visit utilization in a national, population-based sample of adults with osteoarthritis. Arthritis Care Res. 2009;61(12):1694–703. doi:10.1002/art.24897.
  • Curtis JR, Xie F, Smith C, Saag KG, Chen L, Beukelman T, Mannion M, Yun H, Kertesz S. Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States. Arthritis Rheumatol. 2017;69(9):1733–40. doi:10.1002/art.40152.
  • Curtis J, Xie F, Saag K, Chen L, Beukelman T, Mannion M, Yun H. Changing patterns over time in opiate use in U.S. rheumatoid arthritis patients. Arthritis Rheum. 2016;68:4124–25.
  • Curtis JP, Sharma P, Arora T, Bharat A, Barnes I, Morrisey MA, Kilgore M, Saag KG, Wright NC, Yun HG, et al. Physicians’ explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System. Arthritis Care Res. 2013;65:235–43. doi:10.1002/acr.21713.
  • Dale O, Borchgrevink PC, Fredheim OM, Mahic M, Romundstad P, Skurtveit S. Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: impact of gender, age, exercise and prescription of opioids. BMC Public Health. 2015;15(1):461. doi:10.1186/s12889-015-1774-6.
  • Davis MM, Patel MS, Halasyamani LK. Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states. J Gen Intern Med. 2007;22(2):257–63. doi:10.1007/s11606-006-0018-y.
  • DeWitt EM, Lin L, Glick HA, Anstrom KJ, Schulman KA, Reed SD. Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank. Clin Ther. 2009;31(8):1871–80. doi:10.1016/j.clinthera.2009.08.020.
  • Doshi JA, Brandt N, Stuart B. The Impact Of Drug Coverage On COX-2 Inhibitor Use In Medicare: elders with the most generous drug coverage in 2000, not those who met certain clinical criteria, were most likely to use COX-2 inhibitors. Health Aff. 2004;23(Suppl1:W4–94.
  • Dubin RE, Kaplan A, Graves L, Ng VK. Acknowledging stigma: its presence in patient care and medical education. Can Fam Phys. 2017;63:906–08.
  • Edlund SM, Wurm M, Holländare F, Linton SJ, Fruzzetti AE, Tillfors M. Pain patients’ experiences of validation and invalidation from physicians before and after multimodal pain rehabilitation: associations with pain, negative affectivity, and treatment outcome. Scand J Pain. 2017;17(1):77–86. doi:10.1016/j.sjpain.2017.07.007.
  • Elder R, Acheson RM. New Haven survey of joint diseases. XIV Social Class and Behavior in Response to Symptoms of Osteoarthritis Milbank Memorial Fund Quarterly. 1970;48:449–502.
  • Elliott RA. Poor Adherence to Medication in Adults with Rheumatoid Arthritis. Dis Manag Health Out. 2008;16(1):13–29. doi:10.2165/00115677-200816010-00003.
  • Fletcher A, Lassere M, Black R, Barrett C, Caroll G, Lester S, Richards B, March L, Buchbinder R, Hill C. Socioeconomic differences in opioid use by people with inflammatory arthritis. Arthritis Rheumatol. 2018;70.
  • Fletcher A, Lassere M, March L, Buchbinder R, Lester S, Barrett C, Carroll G, Black R, Richards B, Hill C. Socioeconomic differences in opioid use by people with inflammatory arthritis: data from the Australian Rheumatology Association database. Int J Rheum Dis. 2019;22:75.
  • Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M, Cox V, Kallen MA, Janssen N, Ng B, Marcus DM, Reveille JD, Suarez-Almazor ME. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheum. 2008;27:883–89. doi:10.1007/s10067-007-0816-6.
  • Gibbs SN, Shah S, Deshpande CG, Bensink ME, Broder MS, Dumas PK, Buse DC, Vo P, Schwedt TJ. United States Patients’ Perspective of Living With Migraine: country-Specific Results From the Global “My Migraine Voice” Survey. Headache. 2020;60(7):1351–64. doi:10.1111/head.13829.
  • Gilman BH, Gage B, Haber S, Hoover S, Aggarwal J. Impact of drug coverage on medical expenditures among the elderly. Health Care Finan Rev. 2007;29:103.
  • Green MA, Little E, Cooper R, Relton C, Strong M. Investigation of social, demographic and health variations in the usage of prescribed and over-the-counter medicines within a large cohort (South Yorkshire, UK). BMJ Open. 2016;6(9):e012038. doi:10.1136/bmjopen-2016-012038.
  • Harrold LR, Briesacher BA, Peterson DA, Beard A, Madden J, Zhang F, Gurwitz JH, Soumerai SB. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatology. 2013;40:137–43. doi:10.3899/jrheum.120441.
  • Heidari P, Cross W, Weller C, Team V, Nazarinia M, Crawford K. Rheumatologists‘ insight into medication adherence in patients with rheumatoid arthritis: a qualitative study. Int J Rheum Dis. 2019;22(9):1695–705. doi:10.1111/1756-185X.13660.
  • Ison M, Duggan E, Mehdi A, Thomas R, Benham H. Treatment delays for patients with new-onset rheumatoid arthritis presenting to an Australian early arthritis clinic. Intern Med J. 2018;48(12):1498–504. doi:10.1111/imj.13972.
  • Ives TJ, Chelminski PR, Hammett-Stabler CA, Malone RM, Perhac JS, Potisek NM, Shilliday BB, DeWalt DA, Pignone MP. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6(1):46. doi:10.1186/1472-6963-6-46.
  • Jin XM, Lee J, Choi NK, Seong JM, Shin JY, Kim YJ, Kim MS, Yang BR, Park BJ. Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patients. J Korean Med Sci. 2014;29:210–16. doi:10.3346/jkms.2014.29.2.210.
  • Kennedy J, Morgan S. A cross-national study of prescription nonadherence due to cost: data from the joint Canada-United States survey of health. Clin Ther. 2006;28(8):1217–24. doi:10.1016/j.clinthera.2006.07.009.
  • Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14(6):553–60. doi:10.18553/jmcp.2008.14.6.553.
  • Kirsch M, Montgomery JR, Hu HM, Englesbe M, Hallstrom B, Brummett CM, Fendrick AM, Waljee JF. Association between insurance cost-sharing subsidy and postoperative opioid prescription refills among Medicare patients. Surgery. 2020;168(2):244–52. doi:10.1016/j.surg.2020.04.013.
  • Kuipers JG, Koller M, Zeman F, Müller K, Rüffer JU. Adherence and health literacy as related to outcome of patients treated for rheumatoid arthritis: analyses of a large-scale observational study. Z Rheumatol. 2019;78:74–81. doi:10.1007/s00393-018-0449-y.
  • Kurlander JE, Kerr EA, Krein S, Heisler M, Piette JD. Cost-related nonadherence to medications among patients with diabetes and chronic pain: factors beyond finances. Diabetes Care. 2009;32(12):2143–48. doi:10.2337/dc09-1059.
  • Li X, Anis AH. Cost sharing of prescription drugs and demand for health-care utilization among seniors with rheumatoid arthritis. Appl Econ Lett. 2013;20(1):23–27. doi:10.1080/13504851.2012.669456.
  • Lofchie A, Butler N, Robbins M, Seng E. Predictors of non-adherence with acute migraine medications. Neurology. 2019;92:410–002.
  • Löfvendahl S, Jöud A, Petersson IF, Theander E, Å S, Carlsson KS. Income disparities in healthcare use remain after controlling for healthcare need: evidence from Swedish register data on psoriasis and psoriatic arthritis. Eur J Health Econ. 2018;19:447–62. doi:10.1007/s10198-017-0895-5.
  • Menon V, Kelley S. A thousand patient voices: knowledge, impact, and experiences of living with osteoarthritis of the knee. Osteoarthritis Cartilage. 2020;28:S491–2. doi:10.1016/j.joca.2020.02.768.
  • Mukherjee K, Kamal KM. Socio-demographic factors and out-of-pocket expenditure for prescription drugs in rheumatoid arthritis. Value in Health. 2016;19(3):A232. doi:10.1016/j.jval.2016.03.1141.
  • Mukherjee K, Kamal KM. Sociodemographic determinants of out-of-pocket expenditures for patients using prescription drugs for rheumatoid arthritis. Am Health Drug Benefits. 2017;10:7–15.
  • Murphy LB, Yelin E, Theis KA. Compromised access to prescriptions and medical care because of cost among US adults with arthritis. Best Pract Res Clin Rheumatol. 2012;26(5):677–94. doi:10.1016/j.berh.2012.10.007.
  • Musich S, Wang SS, Slindee L, Kraemer S, Yeh CS. Characteristics associated with transition from opioid initiation to chronic opioid use among opioid-naive older adults. Geriatr Nurs. 2019;40:190–96. doi:10.1016/j.gerinurse.2018.10.003.
  • Nair KV, Valuck RJ, Allen RR, Lewis SJ. Impact of increased copayments on the discontinuation/switching rates of nonformulary medications. J Pharm Tech. 2005;21(3):137–43. doi:10.1177/875512250502100304.
  • Nascimben J, Cubbison C, Lape EC, Katz JN. Strategies for managing the costs of chronic illness in the context of limited financial resources: a qualitative study in Dominican persons with arthritis. Arthritis Care & Research. 2019;71(10):1379–86. doi:10.1002/acr.23742.
  • Nierengarten B. Use of disease-modifying antirheumatic drugs low among unsubsidized beneficiaries with rheumatoid arthritis. Ann Long-Term Care. 2013;21:16–17.
  • Oh G, Abner EL, Fardo DW, Freeman PR, Moga DC. Patterns and predictors of chronic opioid use in older adults: a retrospective cohort study. PloS One. 2019a; 14:e0210341.
  • Oh TK, Jeon YT, Choi JW. Trends in chronic opioid use and association with five-year survival in South Korea: a population-based cohort study. Br J Anaesth. 2019b;123:655–63. doi:10.1016/j.bja.2019.08.012.
  • Orhurhu V, Olusunmade M, Urits I, Viswanath O, Peck J, Orhurhu MS, Adekoya P, Hirji S, Sampson J, Simopoulos T, et al. Trends of opioid use disorder among hospitalized patients with chronic pain. Pain Pract. 2019;19(6):656–63. doi:10.1111/papr.12789.
  • Parsons B, Schaefer C, Mann R, Sadosky A, Daniel S, Nalamachu S, Stacey BR, Nieshoff EC, Tuchman M, Anschel A. Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. J Pain Res. 2013;6:459–69. doi:10.2147/JPR.S44939.
  • Parsons LB, Adams J. SAT0762-HPR the Accessibility and Usability of an Australian Web-based Self-management Programme (MYJOINTPAIN) for People with Lower Health Literacy and Joint Pain in the Uk Annals of the Rheumatic Diseases. 2017;76:1525–1526).
  • Patel T, Chang F, Mohammed HT, Raman-Wilms L, Jurcic J, Khan A, Sproule B, Lafrenie RM. Knowledge, perceptions and attitudes toward chronic pain and its management: a cross-sectional survey of frontline pharmacists in Ontario, Canada. PLoS One. 2016;11(6):e0157151. doi:10.1371/journal.pone.0157151.
  • Peacock A, Nielsen S, Bruno R, Campbell G, Larance B, Degenhardt L. Geographic variation in health service use and perceived access barriers for Australian adults with chronic non-cancer pain receiving opioid therapy. Pain Med. 2016;17(11):2003–16. doi:10.1093/pm/pnw109.
  • Power JD, Perruccio AV, Gandhi R, Veillette C, Davey JR, Lewis SJ, Syed K, Mahomed NN, Rampersaud YR. Factors associated with opioid use in presurgical knee, Hip, and spine osteoarthritis patients. Arthritis Care Res. 2019;71(9):1178–85. doi:10.1002/acr.23831.
  • Price-Haywood EG, Burton J, Burstain T, Harden-Barrios J, Lefante J, Shi L, Jamison RN, Bazzano A, Bazzano L. Clinical effectiveness of decision support for prescribing opioids for chronic noncancer pain: a prospective cohort study. Value in Health. 2020;23(2):157–63. doi:10.1016/j.jval.2019.09.2748.
  • Robinson JP, Dansie EJ, Wilson HD, Rapp S, Turk DC. Attitudes and beliefs of working and work-disabled people with chronic pain prescribed long-term opioids. Pain Med. 2015;16(7):1311–24. doi:10.1111/pme.12770.
  • Rosemann T, Joos S, Szecsenyi J, Laux G, Wensing M. Health service utilization patterns of primary care patients with osteoarthritis. BMC Health Serv Res. 2007;7(1):169. doi:10.1186/1472-6963-7-169.
  • Rutledge DN, Rakovski C, Zettel-Watson L. Healthcare underutilization in overweight Mexican Americans with chronic pain. Ethnicity and Inequalities in Health and Social Care. 2012;5(4):123–32. doi:10.1108/EIHSC-10-2012-0010.
  • Salazar DH, Dy CJ, Choate WS, Place HM Disparities in Access to Musculoskeletal Care: narrowing the Gap: AOA Critical Issues Symposium. J Bone Joint Surg Am. 2019;101:e121.
  • Salt E, Frazier SK. Predictors of medication adherence in patients with rheumatoid arthritis. Drug Dev Res. 2011;72(8):756–63. doi:10.1002/ddr.20484.
  • Sawyer P, Bodner EV, Ritchie CS, Allman RM. Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacother. 2006;4(4):316–24. doi:10.1016/j.amjopharm.2006.12.005.
  • Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JJA, Weiss RD. Clinician beliefs and attitudes about buprenorphine/naloxone diversion. The American Journal on Addictions. 2013;22(6):574–80. doi:10.1111/j.1521-0391.2013.12024.x.
  • Schwill U, Kordbarlag C, Reutermann P, Listing J, Zaenker M. SAT0066 Interrelationship between Rheumatoid Arthritis, Poverty and Education. Ann Rheum Dis. 2014;73(Suppl 2):614. doi:10.1136/annrheumdis-2014-eular.3720.
  • Shipton D, Glazier RH, Guan J, Badley EM. Effects of use of specialty services on disease-modifying antirheumatic drug use in the treatment of rheumatoid arthritis in an insured elderly population. Med Care. 2004;42(9):907–13. doi:10.1097/01.mlr.0000135810.39691.f6.
  • Steel N, Hardcastle AC, Bachmann MO, Richards SH, Mounce LT, Clark A, Lang I, Melzer D, Campbell J. Economic inequalities in burden of illness, diagnosis and treatment of five long-term conditions in England: panel study. BMJ Open. 2014;4(10):e005530. doi:10.1136/bmjopen-2014-005530.
  • Sung YK, Cho SK, Kim D, Won S, Lee J, Choe JY, Choi CB, Hong SJ, Jun JB, Kim TH, et al. Factors Associated with Time to Diagnosis from Symptom Onset in Early Rheumatoid Arthritis Patients. Arthritis & Rheumatology. 2014;66:S889.
  • Thorlund JB, Turkiewicz A, Prieto-Alhambra D, Englund M. Inappropriate use of opioids for incident knee and Hip osteoarthritis. Int J Rheum Dis. 2019a;22:71–72.
  • Thorlund JB, Turkiewicz A, Prieto-Alhambra D, Englund M. Inappropriate opioid dispensing in patients with knee and Hip osteoarthritis: a population-based cohort study. Osteoarthritis Cartilage. 2020;28(2):146–53. doi:10.1016/j.joca.2019.10.004.
  • Todd A, Akhter N, Cairns J-M, Kasim A, Walton N, Ellison A, Chazot P, Eldabe S, Bambra C. The Pain Divide: a cross-sectional analysis of chronic pain prevalence, pain intensity and opioid utilisation in England. BMJ Open. 2018;8(7):e023391. doi:10.1136/bmjopen-2018-023391.
  • Trupin L, Barton J, Gina E-Y, Imboden JB, Gross AJ, Schillinger D, Yelin EH. Decisional conflict among vulnerable patient populations with rheumatoid arthritis is associated with limited health literacy and non-English language. Arthritis Rheum. 2012;64:S1027–S1028.
  • Tur‐Sinai A, Shuldiner J, Bentur N. Sociodemographic inequality in joint‐pain medication use among community‐dwelling older adults in Israel. Health Soc Care Community. 2019;27:1167–74. doi:10.1111/hsc.12754.
  • Tzouma V, Grepstad M, Grimaccia F, Kanavos P. Clinical, ethical, and socioeconomic considerations for prescription drug use during pregnancy in women suffering from chronic diseases. Ther Innov Regul Sci. 2015;49:947–56. doi:10.1177/2168479015589820.
  • van der Meer JB, van den Bos J, Mackenbach JP. Socioeconomic differences in the utilization of health services in a Dutch population: the contribution of health status. Health Policy (New York). 1996;37(1):1–18. doi:10.1016/0168-8510(96)87673-1.
  • Viticchi G, Silvestrini M, Falsetti L, Lanciotti C, Cerqua R, Luzzi S, Provinciali L, Bartolini M. Time delay from onset to diagnosis of migraine. Headache. 2011;51(2):232–36. doi:10.1111/j.1526-4610.2010.01778.x.
  • Wabe N, Lee A, Wechalekar M, McWilliams L, Proudman S, Wiese M. Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patients. Int J Clin Pract. 2019;73(7):e13375. doi:10.1111/ijcp.13375.
  • Waimann CA, Marengo MF, De Achaval S, Cox VL, Garcia-Gonzalez A, Reveille JD, Richardson MN, Suarez-Almazor ME. Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. Arthritis Rheum. 2013;65(6):1421–29. doi:10.1002/art.37917.
  • Werber A, Marschall U, L’hoest H, Hauser W, Moradi B, Schiltenwolf M. Opioid therapy in the treatment of chronic pain conditions in Germany. Pain Physician. 2015;18:E323–31. doi:10.36076/ppj/2015.18.E323.
  • White KT, Dillingham TR, González-Fernández M, Rothfield L. Opiates for chronic nonmalignant pain syndromes: can appropriate candidates be identified for outpatient clinic management? Am J Phys Med Rehabil. 2009;88(12):995–1001. doi:10.1097/PHM.0b013e3181bc006e.
  • Wong PK. Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe? Rheumatol Int. 2016;36(11):1535–42. doi:10.1007/s00296-016-3566-4.
  • Yelin E, Murphy L, Cisternas MG, Foreman AJ, Pasta DJ, Helmick CG. Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997. Arthritis Rheumat. 2007;56:1397–407. doi:10.1002/art.22565.
  • Zänker M, Schwill U, Bielecke C, Jacobi A, Sokoll K, Zeidler G, Scheibert A, Reutermann P, Bohl-Bühler M, Engel JM, et al. FRI0584 The vicious circle of educational level, rheumatoid arthritis, and risk of poverty – results of a cross-sectional multicenter study in Germany. Ann Rheum Dis. 2016;75:653. doi:10.1136/annrheumdis-2016-eular.3316.
  • Alvarez-Hernandez E, Upegui-Arango LD, Vazquez-Mellado J, Aranda-Arreola E, Burgos-Vargas R, Pelaez-Ballestas I. Characteristics of adherence, persistence and therapeutic alliance in patients with gout. Annals of Rheumatic Diseases. 2017:1362.
  • Bedene A, Lijfering WM, Niesters M, van Velzen M, Rosendaal FR, Bouvy ML, Dahan A, van Dorp EL. Opioid prescription patterns and risk factors associated with opioid use in the Netherlands. JAMA Network Open. 2019;2(8):e1910223. doi:10.1001/jamanetworkopen.2019.10223.
  • Bowen‐Davies Z, Muller S, Mallen CD, Hayward RA, Gout Severity RE, Status S. Work Absence: a Cross‐Sectional Study in Primary Care. Arthritis Care Res. 2018;70:1822–28. doi:10.1002/acr.23562.
  • Brennan SL, Leslie WD, Lix LM. Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women? Osteoporosis Int. 2014;25(1):273–79. doi:10.1007/s00198-013-2467-6.
  • Connelly M, Glynn EF, Hoffman MA, Bickel J. Rates and predictors of using opioids in the emergency department to treat migraine in adolescents and young adults. Pediatr Emerg Care. 2021;37(12):e981–e987. doi:10.1097/PEC.0000000000001851.
  • Devold HM, Furu K, Skurtveit S, Tverdal A, Falch JA, Sogaard AJ. Does socioeconomic factors influence the persistence in the use of alendronate? a nationwide register study in Norway. Osteoporosis Int. 2010;21:180–81.
  • Gebauer S, Salas J, Scherrer JF. Neighborhood socioeconomic status and receipt of opioid medication for new back pain diagnosis. J Am Board Fam Med. 2017;30(6):775–83. doi:10.3122/jabfm.2017.06.170061.
  • Gu X, Chen TC, Su T-L, Steinke D, Chen LC. Investigating the prescribing trajectory and geographical drug utilisation patterns of gabapentinoids in primary care in England. An Ecological Study Br J Clin Pharmacol. 2021;87:4001–12. doi:10.1111/bcp.14827.
  • Heins JK, Heins A, Grammas M, Costello M, Huang K, Mishra S. Disparities in analgesia and opioid prescribing practices for patients with musculoskeletal pain in the emergency department. J Emerg Nurs. 2006;32(3):219–24. doi:10.1016/j.jen.2006.01.010.
  • Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42(7):626–34. doi:10.1097/01.mlr.0000129352.36733.cc.
  • Hopman P, Heins MJ, Korevaar JC, Rijken M, Schellevis FG. Health care utilization of patients with multiple chronic diseases in the Netherlands: differences and underlying factors. Eur J Intern Med. 2016;35:44–50. doi:10.1016/j.ejim.2016.08.025.
  • Jendi W, Sherbeny F. Description of prescription opioid use among US adults. Value in Health. 2020;23(Suppl 1):S129. doi:10.1016/j.jval.2020.04.295.
  • Laroche F, Guerin J, Azoulay D, Coste J, Perrot S. Fibromyalgia in real life: a national French web-based survey in 4516 patients. Arthritis Rheumatol. 2017;69:10.
  • Lee IH, Park S, Lee EK. Sociodemographic factors influencing the use of injections in South Korean outpatient care. Pharmacoepidemiol Drug Saf. 2014;23:51–59. doi:10.1002/pds.3376.
  • Lovejoy TI, Dobscha SK, Turk DC, Weimer MB, Morasco BJ. Correlates of prescription opioid therapy in Veterans with chronic pain and history of substance use disorder. J Rehabil Res Dev. 2016;53(1):25–36. doi:10.1682/JRRD.2014.10.0230.
  • Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain. 2011;12(9):1004–16. doi:10.1016/j.jpain.2011.04.002.
  • Mordecai L, Reynolds C, Donaldson LJ. de C Williams AC Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study. Br J Gen Pract. 2018;68:e225–e233.
  • Sanger N, Bhatt M, Shams I, Shahid H, Luo C, Tam SL, Samaan MC, de Souza R, Thabane L, Samaan Z. Association between socio-demographic and health functioning variables among patients with opioid use disorder introduced by prescription: a prospective cohort study. Pain Physician. 2018;21:E623–E632.
  • Weiner SS, Weiser SR, Carragee EJ, Nordin M. Managing nonspecific low back pain: do nonclinical patient characteristics matter? Spine. 1987-1994;2011(36).
  • Anis AH, Guh DP, Lacaille D, Marra CA, Rashidi AA, Li X, Esdaile JM. When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ. 2005;173:1335–40. doi:10.1503/cmaj.045146.
  • Balakrishnan S, Bambery P, Gupta N, Pandhi P. An audit of the use of antirheumatic drugs in a North Indian referral hospital. Pharmacoepidemiol Drug Saf. 2001;10(3):237–43. doi:10.1002/pds.591.
  • Bateman C. ‘Opi-phobia’ among doctors leads to unnecessary suffering. S Afr Med J. 2007;97:399–403.
  • Bolge SC, Meyer R, Annunziata K. Regional variations in rheumatoid arthritis treatment and health outcomes across the United States. Arthritis Rheum. 2013;65:S451–S45.
  • Booker S, Herr K, Tripp-Reimer T. Patterns and perceptions of self-management for osteoarthritis pain in African American older adults. Pain Med. 2019;20(8):1489–99. doi:10.1093/pm/pny260.
  • Buonora M, Perez HR, Heo M, Cunningham CO, Starrels JL. Race and gender are associated with opioid dose reduction among patients on chronic opioid therapy. Pain Med. 2019;20(8):1519–27. doi:10.1093/pm/pny137.
  • Burgess DJ, Crowley-Matoka M, Phelan S, Dovidio JF, Kerns R, Roth C, Saha S, van Ryn M. Patient race and physicians‘ decisions to prescribe opioids for chronic low back pain. Soc Sci Med. 2008;67(11):1852–60. doi:10.1016/j.socscimed.2008.09.009.
  • Butcher L. Practice matters: the CGRP inhibitors for migraine are reaching the market. Why Not All Neurologists May Be Able to Prescribe Them Neurology Today. 2018;18:28–31.
  • Canada RE, DiRocco D, Day S. A better approach to opioid prescribing in primary care. J Fam Pract. 2014;63:E1–E8.
  • Carter CT, Tunceli O, Bolge SC, Denny L, Fang C, Singer J. Differences in clinical and economic profiles of rheumatoid arthritis patients using frequently doses subcutaneous or less frequently dosed intravenous biologic therapy. Arthritis Rheum. 2010;62:1542.
  • Charleston L, Burke J. Do racial/ethnic disparities exist in recommended migraine treatments in US ambulatory care? Cephalalgia. 2018;38(5):876–82. doi:10.1177/0333102417716933.
  • Delorme J, Chenaf C, Bertin C, Riquelme M, Eschalier A, Ardid D, Authier N. Chronic pain opioid-maintained patients receive less analgesic opioid prescriptions. Front Psych. 2018:9.
  • Gavan S, Harrison M, Barton A, Hyrich K, Isaacs J, Morgan A, Wilson AG, Payne K. Identifying factors which influence the selection of anti-TNF treatment in patients with rheumatoid arthritis in England. Value in Health. 2016;19(3):A238. doi:10.1016/j.jval.2016.03.1106.
  • Green CR, Hart-Johnson T. The adequacy of chronic pain management prior to presenting at a tertiary care pain center: the role of patient socio-demographic characteristics. J Pain. 2010;11(8):746–54. doi:10.1016/j.jpain.2009.11.003.
  • Grotenhermen F, Schnelle M. Survey on the medical use of cannabis and THC in Germany. Journal of Cannabis Therapeutics. 2003;3(2):17–40. doi:10.1300/J175v03n02_03.
  • Harle CA, Cook RL, Kinsell HS, Harman JS. Opioid prescribing by physicians with and without electronic health records. J Med Syst. 2014;38(11):138. doi:10.1007/s10916-014-0138-6.
  • Heckman BD, Holroyd KA, O’Donnell FJ, Tietjen G, Utley C, Stillman M, Ellis G. Race differences in adherence to headache treatment appointments in persons with headache disorders. J Natl Med Assoc. 2008;100(2):247–55. doi:10.1016/s0027-9684(15)31213-x.
  • Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag. 2014;10:375–82. doi:10.5055/jom.2014.0234.
  • Kalkan A, Hallert E, Carlsson P, Roback K, Sjöwall C. Individual variations in treatment decisions by Swedish rheumatologists regarding biological drugs for rheumatoid arthritis. Scand J Rheumatol. 2015;44(4):265–70. doi:10.3109/03009742.2014.997286.
  • Kim G, Barner JC, Rascati K, Richards K. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis. J Manag Care Spec Pharm. 2015;21(5):401–07. doi:10.18553/jmcp.2015.21.5.401.
  • King C, Liu X. Racial and ethnic disparities in opioid use among US adults with back pain. Spine. 2020;45(15):1062–66. doi:10.1097/BRS.0000000000003466.
  • King L, Marshall DA, Hawker G. Patient factors associated with gaps in osteoarthritis care. Arthritis Rheumatol. 2018;70:472–73.
  • Loder S, Sheikh HU, Loder E. The prevalence, burden, and treatment of severe, frequent, and migraine headaches in US minority populations: statistics from National Survey studies. Headache. 2015;55(2):214–28. doi:10.1111/head.12506.
  • Madsen AM, Stark LM, Has P, Emerson JB, Schulkin J, Matteson KA. Opioid knowledge and prescribing practices among obstetrician–gynecologists. Obstet Gynecol. 2018;131(1):150–57. doi:10.1097/AOG.0000000000002407.
  • Mailis-Gagnon A, Lakha SF, Ou T, Louffat A, Yegneswaran B, Umana M, Cohodarevic T, Nicholson K, Deshpande A. Chronic noncancer pain: characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic. Can Fam Physician. 2011;57:e97–e105.
  • Martin RW, Head AJ, Birmingham JD, Eggebeen AT. Does biased risk perception explain the underuse of disease modifying anti-rheumatic drugs? Arthritis Rheum. 2012;64:S167.
  • Marttinen MK, Kautiainen H, Haanpaa M, Pohjankoski H, Vuorimaa H, Hintikka J, Kauppi M. Pain-associated factors and administration of pain medication in the elderly Finnish population. Scandinavian J Pain. 19:797–803. doi:10.1515/sjpain-2019-0039.
  • Meghani SH, Cho E. Self-Reported Pain and Utilization of Pain Treatment Between Minorities and Nonminorities in the United States. Public Health Nurs. 2009;26(4):307–16. doi:10.1111/j.1525-1446.2009.00785.x.
  • Mikuls TR, Mudano AS, Pulley L, Saag KG. The association of race/ethnicity with the receipt of traditional and alternative arthritis-specific health care. Med Care. 2003;41(11):1233–39. doi:10.1097/01.MLR.0000093422.67436.E5.
  • Moskowitz D, Thom DH, Guzman D, Penko J, Miaskowski C, Kushel M. Is primary care providers’ trust in socially marginalized patients affected by race? J Gen Intern Med. 2011;26(8):846–51. doi:10.1007/s11606-011-1672-2.
  • Movahedi M, Joshi R, Rampakakis E, Thorne C, Cesta A, Sampalis JS, Bombardier C. Impact of residential area on the management of rheumatoid arthritis patients initiating their first biologic DMARD: results from the Ontario Best Practices Research Initiative (OBRI). Medicine. 2019;98(20):e15517. doi:10.1097/MD.0000000000015517.
  • Navarro-Millan I, Rajan M, Lui G, Kern L, Pinheiro L, Safford M, Curtis J. Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis. 2020;50:988–95. doi:10.1016/j.semarthrit.2020.07.008.
  • Nicholson RA, Rooney M, Vo K, O’Laughlin E, Gordon M. Migraine care among different ethnicities: do disparities exist? Headache. 2006;46:754–65. doi:10.1111/j.1526-4610.2006.00453.x.
  • Nieves-Plaza M, Eng H, Metes ID, Shewede A, Wisniewski SR, John A, Levesque MC. Physician and patient characteristics associated with the decision to treat rheumatoid arthritis patients with biologic monotherapy in usual care settings. Arthritis Rheumat. 2013;65:S630.
  • Perez HR, Starrels JL, Gonzalez S, Vidot DC, Hua S, Strizich GM, Zeng D, Daviglus M, Gellman MD, Kaplan RC. Factors associated with prescription opioid use among hispanics/latinos with arthritis results from the hispanic community health study/study of latinos. J Gen Intern Med. 2018;33:200–01.
  • Prunuske JP, St. Hill CA, Hager KD, Lemieux AM, Swanoski MT, Anderson GW, Lutfiyya MN. Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data. BMC Heath Serv Res. 2014;14:563. doi:10.1186/s12913-014-0563-8.
  • Putrik P, Ramiro S, Orueta JF, Keszei A, Alonso-Morán E, Nuño-Solinis R, Boonen A. THU0628 Socio-Economically Deprived Patients Have A Higher Likelihood for Having Any Type of Rheumatic and Musculoskeletal Diseases and Have Higher Healthcare Costs-Results from A Population-Based Administrative Database Including 1.9 Million Persons (Basque Country, Spain). Clin Exp Rheumatol. 2018;36:589–94.
  • Rahme E, J-P R, J-p L, Nedjar H, Morin S. Concordance with guideline recommendations: previous and more recent nonsteroidal anti-inflammatory drug prescriptions in Quebec, Canada. Pharmacoepidemiol Drug Safety. 2012;21:420–27. doi:10.1002/pds.2339.
  • Robinson S. Poor, scared, and hurting: the experiences of Black elders managing chronic pain. J Pain. 2015;16:S36. doi:10.1016/j.jpain.2015.01.156.
  • Rogers KD, Kemp A, McLachlan AJ, Blyth F, Landau R. Adverse selection? a multi-dimensional profile of people dispensed opioid analgesics for persistent non-cancer pain. PLoS ONE. 2013;8(12):e80095. doi:10.1371/journal.pone.0080095.
  • Salas J, Scherrer JF, Lustman PJ, Schneider FD. Racial differences in the association between nonmedical prescription opioid use, abuse/dependence, and major depression. Subst Abus. 2016;37(1):25–30. doi:10.1080/08897077.2015.1129523.
  • Taff J, Loewenstein J, Wang L, Schwartz K, Wei D. Predictors of opiate prescription for low back pain in outpatient emergency care settings. J Gen Intern Med. 2014;29:S178.
  • Turk DC, Brody MC, Okifuji AE. Physicians‘ attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain. 1994;59(2):201–08. doi:10.1016/0304-3959(94)90072-8.
  • Vina E, Hannon M, Dagnino J, Kent Kwoh C. Understanding ethnic differences in the utilization of nonsteroidal anti-inflammatory drugs for osteoarthritis. Ann Rheum Dis. 2019;78:605.
  • Webster BS, Cifuentes M, Verma S, Pransky G. Geographic variation in opioid prescribing for acute, work-related, low back pain and associated factors: a multilevel analysis. Am J Ind Med. 2009;52(2):162–71. doi:10.1002/ajim.20655.
  • Webster F, Rice K, Katz J, Bhattacharyya O, Dale C, Upshur R, Koester S. An ethnography of chronic pain management in primary care: the social organization of physicians’ work in the midst of the opioid crisis. PLoS One. 2019;14(5):e0215148. doi:10.1371/journal.pone.0215148.
  • Wilson FA, Mosalpuria K, Stimpson JP. Association Between Opioid Prescriptions and Non–US-Born Status in the US. JAMA Network Open. 2020;3(6):e206745. doi:10.1001/jamanetworkopen.2020.6745.
  • Birke H, Kurita GP, Sjøgren P, Højsted J, Simonsen MK, Juel K, Ekholm O. Chronic non-cancer pain and the epidemic prescription of opioids in the Danish population: trends from 2000 to 2013. Acta Anaesthesiol Scand. 2016;60(5):623–33. doi:10.1111/aas.12700.
  • Chang SC, Ma CC, Lee CT, Hsieh SW. Pharmacoepidemiology of chronic noncancer pain patients requiring chronic opioid therapy: a nationwide population-based study. Acta Anaesthesiol Taiwan. 2015;53:89–94. doi:10.1016/j.aat.2015.04.002.
  • Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J. Incidence of Rheumatoid Arthritis in Sweden: a Nationwide Population-Based Assessment of Incidence, Its Determinants, and Treatment Penetration. Arthritis Care Res. 2013;65(6):870–78. doi:10.1002/acr.21900.
  • Frakes KA, Brownie S, Davies L, Thomas J, Miller ME, Tyack Z. The sociodemographic and health‐related characteristics of a regional population with chronic disease at an interprofessional student‐assisted clinic in Queensland Capricornia Allied Health Partnership. Aust J Rural Health. 2013;21:97–104. doi:10.1111/ajr.12017.
  • Goodwin JS, Nguyen-Oghalai TU, Kuo Y-F, Ottenbacher KJ. Epidemiology of Medicare abuse: the example of power wheelchairs. J Am Geriatr Soc. 2007;55(2):221–26. doi:10.1111/j.1532-5415.2007.01063.x.
  • Hawley S, Edwards CJ, Arden NK, Delmestri A, Cooper C, Judge A, Prieto-Alhambra D. Descriptive epidemiology of Hip and knee replacement of rheumatoid arthritis patients in England and Wales: variation by sex, age, geography and socio-economic status. Semin Arthritis Rheum. 2020;50:237–44. doi:10.1016/j.semarthrit.2019.08.008.
  • Hussain S, Wang Y, Peeters G, Wluka AE, Mishra GD, Teede H, Urquhart D, Brown WJ, Cicuttini FM. Demographic, psychosocial factors, musculoskeletal pain and prescription opioid use in community-based middle-aged women - a prospective cohort study. Osteoarthritis Cartilage. 2020;28:S140. doi:10.1016/j.joca.2020.02.231.
  • Kashefi S, Lee SM, Mallaysamy S, Thunga PG. Demographic, clinical characteristics and drug prescription pattern in patients with rheumatoid arthritis in south Indian tertiary care hospital. International Journal of Pharmacy and Pharmaceutical Sciences. 2016;8:251–57.
  • Luo X, Pietrobon R, Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine. 2004;29(8):884–90. doi:10.1097/00007632-200404150-00012.
  • Malon J, Shah P, Koh WY, Cattabriga G, Li E, Cao L. Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database. BMC Public Health. 2018;18(1):1–2. doi:10.1186/s12889-018-5673-5.
  • McBurney CA, Vina ER. Racial and ethnic disparities in rheumatoid arthritis. Current Rheumatology Reports. 2012;14(5):463–71. doi:10.1007/s11926-012-0276-0.
  • Miller GE, Moriya AS Any use and frequent use of opioids among non-elderly adults in 2015-2016, by socioeconomic characteristics. In Statistical Brief (Medical Expenditure Panel Survey); Rockville (MD): Agency for Healthcare Research and Quality; 2001: #515.
  • Moody B, Lane M, Botts S, Talbert J. Eastern Kentucky opiate use for chronic non-malignant pain. J Pharm Pract. 2010;23:178.
  • Moriya AS, Miller GE. 2001. Any use and frequent use of opioids among elderly adults in 2015-2016, by socioeconomic characteristics. Agency for Healthcare Research and Quality.
  • Neovius M, Simard JF, Askling J; Neovius M, Simard JF, Askling J, ARTIS Study Group. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis. 2011;70(4):624–29. doi:10.1136/ard.2010.133371.
  • Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain. 2008;138(3):507–13. doi:10.1016/j.pain.2008.01.027.
  • Lee SW, Shen J, Kim SJ, Chun S-Y, Kim P, Riaz J, Yoo JW, Hwang J. US trends of opioid-use disorders and associated factors among hospitalized patients with spinal conditions and treatment from 2005 to 2014. Spine. 2020;45(2):124–33. doi:10.1097/BRS.0000000000003183.
  • Solomon DH, Avorn J, Wang PS, Vaillant G, Cabral D, Mogun H, Stürmer T. Prescription opioid use among older adults with arthritis or low back pain. Arthritis Care Res. 2006;55(1):35–41. doi:10.1002/art.21697.
  • Wei YJ, Chen C, Fillingim R, Schmidt SO, Winterstein AG, Strathdee S. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: a cross-sectional study. PLoS Med. 2019;16(11):e1002941. doi:10.1371/journal.pmed.1002941.
  • Campbell G, Nielsen S, Bruno R, Lintzeris N, Cohen M, Hall W, Larance B, Mattick RP, Degenhardt L. The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain. 2015;156(2):231–42. doi:10.1097/01.j.pain.0000460303.63948.8e.
  • Campbell NK, Saadeldin K, De Vera MA. The duality of economic issues with medication non-adherence in patients with inflammatory arthritis. Curr Rheumatol Rep. 2017;19(10):66. doi:10.1007/s11926-017-0691-3.
  • Charleston IVL, Royce J, Monteith TS, Broner SW, O’Brien HL, Manrriquez SL, Robbins MS. Migraine care challenges and strategies in US uninsured and underinsured adults: a narrative review, part 2. Headache. 2018;58(5):633–47. doi:10.1111/head.13321.
  • Duggan A, Hayes C. Variation in dispensing of opioid analgesics in Australia. Intern Med J. 2017;47(4):473–74. doi:10.1111/imj.13394.
  • Gulliford M. Opioid use, chronic pain and deprivation. eClinicalMedicine. 2020 Apr;21(21):100341. doi:10.1016/j.eclinm.2020.100341.
  • Hadler NM. Socioeconomics of back pain. Nat Clin Pract Rheumatol. 2006;2(5):230–31. doi:10.1038/ncprheum0170.
  • Karran EL, Grant AR, Moseley L. Low back pain and the social determinants of health: a systematic review and narrative synthesis. Pain. 2020;161(11):2476–93. doi:10.1097/j.pain.0000000000001944.
  • Knight KR, Kushel M, Chang JS, Zamora K, Ceasar R, Hurstak E, Miaskowski C. Opioid pharmacovigilance: a clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use. Soc Sci Med. 2017;186:87–95. doi:10.1016/j.socscimed.2017.05.043.
  • Lasser KE. Prescription opioid use among US adults: our Brave New World. AnnIntern Med. 2017;167:351–52.
  • Lekpa FK, Ndongo S, Pouye A, Zeba D, Ka O, Doualla M-S, Luma HN, Ka MM, Diop TM. Authors‘ reply to the comment by Pazzaglia et al. Eur J Pain. 2013;17(6):946–47. doi:10.1002/j.1532-2149.2013.00304.x.
  • Li E, Khan Z, Balu S. A systematic review of the association between patient out-of-pocket costs and the non-initiation of biologics used to treat rheumatoid arthritis. J Manag Care Spec Pharm. 2018;25:S83.
  • Losby JL, Hyatt JD, Kanter MH, Baldwin G, Matsuoka D. Safer and more appropriate opioid prescribing: a large healthcare system’s comprehensive approach. J Eval Clin Pract. 2017;23:1173–79. doi:10.1111/jep.12756.
  • Meghani SH, Byun E, Gallagher RM. Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Med. 2012;13(2):150–74. doi:10.1111/j.1526-4637.2011.01310.x.
  • Mody GM, Cardiel MH. Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol. 2008;22(4):621–41. doi:10.1016/j.berh.2008.04.003.
  • Richards GC, Mahtani KR, Muthee TB, DeVito NJ, Koshiaris C, Aronson JK, Goldacre B, Heneghan CJ. Factors associated with the prescribing of high-dose opioids in primary care: a systematic review and meta-analysis. BMC Med. 2020;18(1):68. doi:10.1186/s12916-020-01528-7.
  • Roa JA, Guevara A, Guevara C, Guevara-Aguirre J. Physician’s role in prescribing opioids in developing countries. BMJ Case Reports CP. 2019;12(6):e227072. doi:10.1136/bcr-2018-227072.
  • Stewart J, Kempenaar L, Lauchlan D. Rethinking yellow flags. Man Ther. 2011;16(2):196–98. doi:10.1016/j.math.2010.11.005.
  • The Back Letter. Why are disadvantaged whites with chronic pain and other problems dying prematurely? 2016;31:90–93.
  • Baser O, Wang L, Lewis-Beck C, Wang H, Li L, Xie L. Demographic and socioeconomic characteristics that affect selection of intravenous versus subcutaneous injection tumor necrosis factor inhibitors for rheumatoid arthritis. Value in Health. 2012;15:A454. doi:10.1016/j.jval.2012.08.1433.
  • Codreanu C, Mogosan C, Ionescu R, Ancuta I, Parvu M, Rednic S. Area of residence and socioeconomic factors significantly affect access to biological therapy for rheumatoid arthritis patients in Romania. Arthritis Rheum. 2014;66:S507.
  • McKeown T, Jacob B, Li X, Couto S, Bensen W, Ahluwalia V, Karasik A, Bombardier C. Comparison of medication use in rheumatoid arthritis patients between university and private settings – results from Ontario Best Practice Research Initiative. Arthritis Rheumatol. 2014;66:S1058.
  • Putrik P, Ramiro S, Lie E, Keszei A, Van Der Heijde D, Landewé R, Kvien TK, Uhlig T, Boonen A. Level of education is associated with access to biologic DMARDS even in a country with highly developed social welfare (Norway). Ann Rheum Dis. 2014;73:87. doi:10.1136/annrheumdis-2014-eular.2036.
  • Tatangelo M, Tomlinson GA, Paterson M, Bansback N, Gomes T, Kopp A, Ahluwalia V, Bombardier C. The effect of patient, prescriber and region on the initiation of first biologic for rheumatoid arthritis: a longitudinal population study. Arthritis Rheumatol. 2018;70:289–90.
  • Cairns J, Hall N, Walton N, Elison A, Chazot P, Todd A, Eldabe S, Bambra C. Geo-pain: a cross-sectional analysis of spatial inequalities in chronic pain, opioid prescribing and usage in England. Br J Pain. 2017;11:30–31.
  • Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM. Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Medicine. 2011;5:E13.
  • Guzmán-Ruiz M, Mora-Moscoso R, Delgado-Mediano CM, Pérez-Milena A, Rueda-Rojas M, Gea-Rodríguez LA. Managing chronic pain in primary care, prescription profile for strong opioids: indications, cost and adverse effects. Revista de la Sociedad Espanola Del Dolor. 2014;21:197–204. doi:10.4321/S1134-80462014000400003.
  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffman TC, Mulrow CD, Shamseer L, Tetzlafff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
  • Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129–36. doi:10.1126/science.847460.
  • Newman AK, Van Dyke BP, Torres CA, Baxter JW, Eyer JC, Kapoor S, Thorn BE. The relationship of sociodemographic and psychological variables with chronic pain variables in a low-income population. Pain. 2017;158(9):1687–96. doi:10.1097/j.pain.0000000000000964.
  • Davey Smith G. Learning to live with complexity: ethnicity, socioeconomic position, and health in Britain and the United States. Am J Public Health. 2000;90:1694–98.
  • Fuentes M, Hart-Johnson T, Green CR. The association among neighborhood socioeconomic status, race and chronic pain in black and white older adults. J Natl Med Assoc. 2007;99:1160–69.
  • Becker WC, Dorflinger L, Edmond SN, Islam L, Heapy AA, Fraenkel L. Barriers and facilitators to use of non-pharmacological treatments in chronic pain. BMC Fam Pract. 2017;18(1):41. doi:10.1186/s12875-017-0608-2.
  • Weeks WJ. Influential U.S. Medical Organizations Call for Insurance Coverage of Non-Pharmacologic Approaches to Pain. J Altern Complement Med. 2016;22(12):947–49. doi:10.1089/acm.2016.29016.jjw.
  • Donovan HS, Ward SE, Song M-K, Heidrich SM, Gunnarsdottir S, Phillips CM. An update on the representational approach to patient education. J Nurs Scholar. 2007;39:259–65. doi:10.1111/j.1547-5069.2007.00178.x.
  • McCauley JL, Back SE, Brady KT. Pilot of a brief, web-based educational intervention targeting safe storage and disposal of prescription opioids. Addictive Behav. 2013;38:2230–35. doi:10.1016/j.addbeh.2013.01.019.
  • Rimer BK, Kedziera P, Levy MH. The role of patient education in cancer pain control. Hospice J. 1992;8:171–91. doi:10.1300/J011v08n01_08.
  • Hollingshead NA, Matthias MS, Bair M, Hirsh AT. Healthcare providers’ perceptions of socioeconomically disadvantaged patients with chronic pain: a qualitative investigation. J Health Dispar Res Pract. 2016;9:3.
  • Joynt M, Train MK, Robbins BW, Halterman JS, Caiola E, Fortuna RJ. The impact of neighborhood socioeconomic status and race on the prescribing of opioids in emergency departments throughout the United States. J Gen Intern Med. 2013;28(12):1604–10. doi:10.1007/s11606-013-2516-z.
  • Reyes-Gibby CC, Aday LA, Todd KH, Cleeland CS, Anderson KO. Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic Blacks, and Hispanics. J Pain. 2007;8:75–84.
  • Clark J, Potter D, McKinlay J. Bringing social structure back into clinical decision making. Soc Sci Med. 1991;32(8):853–66. doi:10.1016/0277-9536(91)90241-4.
  • Eisenberg JM. Sociologic Influences on Decision-Making by Clinicians. Ann Intern Med. 1979;90(6):957–64. doi:10.7326/0003-4819-90-6-957.
  • Chibnall JT, Dabney A, Tait R. Internist Judgments of Chronic Low Back Pain. Pain Med. 2000;1(3):231–37. doi:10.1046/j.1526-4637.2000.00029.x.
  • Gatchel RJ, Polatin PB, Kinney RK. Predicting outcome of chronic back pain using clinical predictors of psychopathology: a prospective analysis. Health Psychol. 1995;14(5):415–20. doi:10.1037/0278-6133.14.5.415.
  • Hausmann LRM, Gao S, Lee ES, Kwoh KC. Racial disparities in the monitoring of patients on chronic opioid therapy. Pain. 2013;154(1):46–52. doi:10.1016/j.pain.2012.07.034.
  • Tait RC, Chibnall JT. Work injury management of refractory low back pain: relations with ethnicity, legal representation and diagnosis. Pain. 2001;91(1):47–56. doi:10.1016/S0304-3959(00)00418-8.
  • Diniz E, Castro P, Bousfield A, Bernardes SF. Classism and dehumanization in chronic pain: a qualitative study of nurses’ inferences about women of different socio-economic status. Br J Health Psychol. 2019;25:152–70. doi:10.1111/bjhp.12399.
  • Green CR, Baker TA, Smith EM, Sato Y. The effect of race in older adults presenting for chronic pain management: a comparative study of Black and White Americans. J Pain. 2003b;4(2):82–90. doi:10.1054/jpai.2003.8.
  • Becker WC, Starrels JL, Heo M, Li X, Weiner MG, Turner BJ. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med. 2011;9(3):219–25. doi:10.1370/afm.1242.
  • Davies KA, Silman AJ, Macfarlane GJ, Nicholl BI, Dickens C, Morriss R, Ray D, McBeth J. The association between neighbourhood socio-economic status and the onset of chronic widespread pain: results from the EPIFUND study. Eur J Pain. 2009;13(6):635–40. doi:10.1016/j.ejpain.2008.07.003.
  • Maly A, Vallerand AH. Neighborhood, socioeconomic, and racial influence on chronic pain. Pain Manag Nurs. 2018;19:14–22. doi:10.1016/j.pmn.2017.11.004.
  • Jordan KM, Sawyer S, Coakley P, Smith HE, Cooper C, Arden NK The use of conventional and complementary treatments for knee.
  • Ruhe A-K, Wager J, Hirschfeld G, Zernikow B. Household income determines access to specialized pediatric chronic pain treatment in Germany. BMC Health Serv Res. 2016;16(1):140. doi:10.1186/s12913-016-1403-9.
  • Morrison RS, Wallenstein S, Natale DK, Senzel RS, Huang LL. “We don’t carry that”: failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med. 2000;342:1023–26. doi:10.1056/NEJM200004063421406.
  • Green CR, Baker TA, Sato Y, Washington TL, Smith EM. Race and chronic pain: a comparative study of young Black and White Americans presenting for management. J Pain. 2003c;4(4):176–83. doi:10.1016/S1526-5900(02)65013-8.
  • Shavers VL, Bakos A, Sheppard VB. Race, Ethnicity, and Pain among the U.S. Adult Population. J Health Care Poor Underserved. 2010;21(1):177–220. doi:10.1353/hpu.0.0255.
  • Vallerand AH, Pieper B, Crawley J, Nordstrom C, DiNardo E. The prevalence of pain and its association with psychosocial factors for indigent adults enrolled in a primary care clinic. Clin J Pain. 2013;29(10):917–23. doi:10.1097/AJP.0b013e31827c7b30.
  • Dovidio JF, Fiske ST. Under the radar: how unexamined biases in decision-making processes in clinical interactions can contribute to health care disparities. Am J Public Health. 2012;102(5):945–52. doi:10.2105/AJPH.2011.300601.
  • Crenshaw K. Demarginalizing the intersection of race and sex: a black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics. Univ Chic Leg Forum. 1989;140:139–1676.
  • Mackey LM, Blake C, Casey M-B, Power CK, Victory R, Hearty C, Fullen BM. The impact of health literacy on health outcomes in individuals with chronic pain: a cross-sectional study. Physiotherapy. 2019;105(3):346–53. doi:10.1016/j.physio.2018.11.006.
  • Mackert M, Ball J, Lopez N. Health literacy awareness training for healthcare workers: improving knowledge and intentions to use clear communication techniques. Patient Educ Couns. 2011;85(3):e225–e228. doi:10.1016/j.pec.2011.02.022.
  • Miller TA. Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis. Patient Educ Couns. 2016;99(7):1079–86. doi:10.1016/j.pec.2016.01.020.
  • Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-Centered Communication, Ratings of Care, and Concordance of Patient and Physician Race. Ann Intern Med. 2003;139(11):907–15. doi:10.7326/0003-4819-139-11-200312020-00009.
  • Schillinger D, Bindman A, Wang F, Stewart A, Piette J. Functional health literacy and the quality of physician–patient communication among diabetes patients. Patient Educ Couns. 2004;52(3):315–23. doi:10.1016/S0738-3991(03)00107-1.
  • Shaw A, Ibrahim S, Reid F, Ussher M, Rowlands G. Patients’ perspectives of the doctor–patient relationship and information giving across a range of literacy levels. Patient Educ Couns. 2009;75(1):114–20. doi:10.1016/j.pec.2008.09.026.
  • Kolhatkar A, Cheng L, Morgan SG, Goldsmith LJ, Dhalla IA, Holbrook AM, Law MR. Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis. CMAJ Open. 2018;6(4):E544–E550. doi:10.9778/cmajo.20180063.
  • Alexander GC, Casalino LP, Meltzer DO. Physician strategies to reduce patients’ out-of-pocket prescription costs. Arch Intern Med. 2005;165(6):633–36. doi:10.1001/archinte.165.6.633.
  • Alexander GC, Casalino LP, Tseng C-W, McFadden D, Meltzer DO. Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med. 2004;19(8):856–60. doi:10.1111/j.1525-1497.2004.30249.x.
  • Goldacre B, Reynolds C, Powell-Smith A, Walker AJ, Yates TA, Croker R, Smeeth L. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? a cross-sectional analysis of English primary care prescribing data. BMJ Open. 2019;9:e026886.
  • Gaffney A, Bor DH, Himmelstein DU, Woolhandler S, McCormick D. The effect of Veterans Health Administration coverage on cost-related medication nonadherence. Health Aff. 2020;1:33–40.
  • Ghosh A, Simon K, Sommers BD. The effect of health insurance on prescription drug use among low-income Adults:evidence from recent Medicaid Expansions. J Health Econ. 2019;63:64–80. doi:10.1016/j.jhealeco.2018.11.002.
  • Hill SC, Abdus S. The effects of Medicaid on access to care and adherence to recommended preventive services. Health Serv Res. 2021;56(1):84–94. doi:10.1111/1475-6773.13603.
  • Kirsch M, Montgomery JR, Hu HM, Englesbe M, Hallstrom B, Brummett CM, Fendrick AM, Waljee JF. Association between insurance cost-sharing subsidy and postoperative opioid prescription refills among Medicare patients. Surgery. 2020;168:244–52.
  • Cong M, Chaisson J, Cantrell D, Mohundro BL, Carby M, Ford M, Liu M, Kemp LS, Ouyang J, Zhang Y, et al. Association of co-pay elimination with medication adherence and total cost. Am J Manag Care. 2021;27:249–54.
  • Vogler S, Dedet G, Pedersen HB. Financial burden of prescribed medicines included in outpatient benefits package schemes: comparative analysis of co-payments for reimbursable medicines in European countries. Appl Health Econ Health Pol. 2019;17:803–16.
  • Department of Health and Wellness, Province of Nova Scotia. Nova Scotia’s Opioid Use and Overdose Framework. https://novascotia.ca/opioid/nova-scotia-opioid-use-and-overdose-framework.pdf [accessed 27 April, 2022].
  • Guo EX, Sweetman A, Guindon GE. Socioeconomic differences in prescription drug supplemental coverage in Canada: a repeated cross-sectional study. Health Pol. 2020;124:252–60.
  • Rawson NSB. National pharmacare in Canada: equality or equity, accessibility or affordability. Int J Health Policy Manag. 2020;9:524–27.
  • Patel MR, Press VG, Gerald LB, Barnes T, Blake K, Brown LK, Costello RW, Crim C, Forshag M, Gershon AS, et al. Imroving the affordability of prescription medications for people with chronic respiratory disease. Am J Respir Crit Care Med. 2018;198:1367–74.